Kevin Alan Schulman

Adjunct Professor in the Department of Medicine
Director, Center for Clinical and Genetic Economics
Research Professor of Global Health
Associate of the Duke Initiative for Science & Society
Member in the Duke Clinical Research Institute
Member of the Duke Cancer Institute
Email address kevin.schulman@duke.edu

Kevin A. Schulman, MD, MBA, is a professor of medicine and the Gregory Mario and Jeremy Mario Professor of Business Administration (2010 - 2016) at Duke University. He is a visiting professor of business administration at Harvard Business School. He holds several leadership appointments at Duke. He is an associate director of the Duke Clinical Research Institute in the School of Medicine, the country's largest academic clinical research organization. In Duke's Fuqua School of Business, he served for more than a decade as the director of the Health Sector Management program, the Master of Management in Clinical Informatics degree program, and the Center for the Study of Health Management. His other university affiliations include the Trent Center for Bioethics, Humanities and History of Medicine; the Duke Translational Medicine Institute; and the Duke Global Health Institute.

Dr. Schulman is a distinguished researcher who has received more than $48 million in research grants. His research interests include health services research and policy, including access to care and the impact of reimbursement and regulatory policies on clinical practice; health economics and economic evaluation in clinical research; and medical decision making, especially in patients with life-threatening conditions. He teaches courses in biotechnology, health policy, and health IT strategy.

Dr. Schulman has published nearly 400 articles and book chapters; his peer-reviewed papers have appeared in the New England Journal of Medicine, JAMA, and Annals of Internal Medicine. He is the senior associate editor of Health Services Research and a member of the editorial/advisory boards of the American Journal of Medicine and the American Heart Journal.

A recipient of numerous awards, Dr. Schulman is a fellow of the American College of Physicians and an elected member of the American Society for Clinical Investigation. He is a voting member of the Medicare Evidence Development and Coverage Advisory Committee. He has served as session chair and panelist at dozens of medical and health care conferences. Dr. Schulman has also served on numerous grant review committees for the National Institutes of Health, the Robert Wood Johnson Foundation, and other bodies. He is a member of the advisory board for the Centre for Healthcare Policy and Management at the China Europe International Business School. In 2010-2011, he was a mentor for the Commonwealth Fund's Harkness Fellowships in Health Care Policy and Practice. He is the founding president of the Business School Alliance for Health Management, a consortium of the leading business schools offering health management programs.

Dr. Schulman received his MD from the New York University School of Medicine and his MBA, with a concentration in health care management, from the Wharton School of the University of Pennsylvania. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and is board-certified in internal medicine.

Publications

Curtis, Lesley H., Bradley G. Hammill, Laura G. Qualls, Lisa D. DiMartino, Fang Wang, Kevin A. Schulman, and Scott W. Cousins. “Treatment patterns for neovascular age-related macular degeneration: analysis of 284 380 medicare beneficiaries..” Am J Ophthalmol 153, no. 6 (June 2012): 1116-24.e1. https://doi.org/10.1016/j.ajo.2011.11.032.

PMID
22321802
Full Text

Hirsch, BR, Mitchell, A, Cheng, SK, Tasneem, A, Schulman, KA, Dilts, DM, and Abernethy, AP. "Improving the impact of clinical research: A systematic analysis of kidney cancer trials." May 20, 2012.

Scholars@Duke

Baras, AI, Baras, AS, and Schulman, KA. "Drug development risk and the cost of capital." Nature Reviews. Drug Discovery 11, no. 5 (May 2012): 347-348.

PMID
22498751
Full Text

Patel, Uptal D., and Kevin A. Schulman. “Invited Commentary-Can We Begin With the End in Mind? End-of-Life Care Preferences Before Long-term Dialysis..” Arch Intern Med 172, no. 8 (April 23, 2012): 663–64. https://doi.org/10.1001/archinternmed.2012.1151.

PMID
23446995
Full Text

Dinan, Michaela A., Timothy J. Robinson, Timothy M. Zagar, Charles D. Scales, Lesley H. Curtis, Shelby D. Reed, W Robert Lee, and Kevin A. Schulman. “Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007..” Int J Radiat Oncol Biol Phys 82, no. 5 (April 1, 2012): e781–86. https://doi.org/10.1016/j.ijrobp.2011.11.024.

PMID
22331001
Full Text

Dewitt, Esi Morgan, Chelsea A. Grussemeyer, Joëlle Y. Friedman, Michaela A. Dinan, Li Lin, Kevin A. Schulman, and Shelby D. Reed. “Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial..” Value Health 15, no. 2 (March 2012): 277–83. https://doi.org/10.1016/j.jval.2011.11.027.

PMID
22433759
Full Text

Glickman, Seth W., Sam Galhenage, Lindsay McNair, Zachry Barber, Keyur Patel, Kevin A. Schulman, and John G. McHutchison. “The potential influence of Internet-based social networking on the conduct of clinical research studies..” J Empir Res Hum Res Ethics 7, no. 1 (February 2012): 71–80. https://doi.org/10.1525/jer.2012.7.1.71.

PMID
22378136
Full Text

Reed, Shelby D., Yanhong Li, Shital Kamble, Daniel Polsky, Felicia L. Graham, Margaret T. Bowers, Gregory P. Samsa, et al. “Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions..” Circ Cardiovasc Qual Outcomes 5, no. 1 (January 2012): 113–19. https://doi.org/10.1161/CIRCOUTCOMES.111.962977.

PMID
22147884
Full Text

Pages